Finzati - Logo
RNAZ logo

TransCode Therapeutics, Inc.

RNAZ • Biotechnology
$2.06
▼ -0.09 (-4.41%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$3.40M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 6.29Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 20, 2026, 12:22 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$2.06
Change-4.41%
Market Cap$3.40M
52W Range2.94 - 20.99
Beta1.24
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio6.29
Quick Ratio6.29
Volume72.61K

Investment DNA

How strong this company looks for long-term investors

47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 6.29Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 7/8/2021
Industry: Biotechnology
P/B i: 0.46
Debt / Equity i: 0.00
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.00
Current Ratio: 6.29
Quick Ratio: 6.29
Status: Good

Insider Transactions

Recent executive and insider activity

DEFJ, LLC
Transaction: 08/03/2026
SELL
Change
—
Price
Not reported
Filing
08/05/2026
Type
SELL
DEFJ, LLC
Transaction: 08/03/2026
SELL
Change
—
Price
Not reported
Filing
08/05/2026
Type
SELL
DEFJ, LLC
Transaction: 08/03/2026
BUY
Change
+11,813,859
Price
$0.00
Filing
08/05/2026
Type
BUY